You have 9 free searches left this month | for more free features.

COVID-19; SARS-CoV-2

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

SARS-CoV-2 Vaccination on Cancer Patients Infected With

Recruiting
  • COVID-19 Infection
  • COVID-19 Vaccine
  • no intervention
  • Beijing, Beijing, China
    Sanhuan Cancer Hospital, Chaoyang District, Beijing(Cancer Hospi
Mar 7, 2023

Long COVID Trial in München

Recruiting
  • Long COVID
    • München, Germany
      München Klinik Schwabing
    Dec 13, 2022

    COVID-19 Trial in Wong Chuk Hang (SARS-CoV-2 DNA Vaccine (ICCOV))

    Recruiting
    • COVID-19
    • SARS-CoV-2 DNA Vaccine (ICCOV)
    • Wong Chuk Hang, Hong Kong
      Gleneagles Hospital Hong Kong
    Jun 16, 2023

    Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Test

    Not yet recruiting
    • SARS-CoV-2
    • +3 more
    • LumiraDx SARS-CoV-2 & Flu A/B
    • Cullman, Alabama
      Cullman Clinical Trials
    Mar 16, 2023

    Sars-Covid-19 Vaccines in Haematological Patients: Prospective

    Completed
    • Hematologic Diseases
    • IgG antibodies to Sars-Cov-2
    • QuantiFERON SARS-CoV-2 test
    • Monza, Lombardia, Italy
      San Gerardo Hospital
    Jan 23, 2023

    SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive

    Not yet recruiting
    • COVID-19
    • +5 more
    • imPulse™ Una infrasound-to-ultrasound e-stethoscope
    • (no location specified)
    Mar 9, 2023

    Truenat™MTB Plus/COVID-19 Test for TB and COVID-19

    Not yet recruiting
    • TB
    • COVID-19
    • Truenat™ MTB Plus/COVID-19
    • (no location specified)
    Jun 10, 2022

    Vitamin A and E Deficiency With Severity of SARS-COV-2 Disease:

    Completed
    • COVID-19
      • Cairo, None Selected, Egypt
        balsam Sherif Fahmy
      Jul 12, 2023

      Covid19, SARS-COV-2 Infection Trial (DWJ1248, Placebo)

      Terminated
      • Covid19
      • SARS-COV-2 Infection
      • Seoul, Korea, Republic of
        Samsung Medical Center
      Dec 4, 2022

      Long COVID, Post-Acute Sequela of COVID-19, Post-Acute COVID-19 Trial in San Francisco (AER002, Placebo)

      Not yet recruiting
      • Long COVID
      • +2 more
      • San Francisco, California
        UCSF/Zuckerberg San Francisco General Hospital
      Jun 2, 2023

      Zinc Deficiency, Sars-CoV-2 Infection Trial in Barcelona (Zinc Acetate)

      Completed
      • Zinc Deficiency
      • Sars-CoV-2 Infection
      • Zinc Acetate
      • Barcelona, Spain
        Hospital del Mar
      Mar 18, 2023

      A Study of the Effectiveness of Moderna COVID-19 Vaccine

      Recruiting
      • SARS-CoV-2
      • COVID-19
      • mRNA-1273
      • Pasadena, California
        Kaiser Permanente Southern California
      Jul 5, 2023

      COVID-19, SARS-CoV2 Trial in Copenhagen (High intensity interval training, Standard care)

      Completed
      • COVID-19, SARS-CoV2
      • High intensity interval training
      • Standard care
      • Copenhagen, Denmark
        Rigshospitalet
      Jun 3, 2022

      Description of Immunologic, Enzymatic and Metabolic Biomarkers

      Recruiting
      • Covid19
      • Blood collection at Day 8, Day 16, Day 24, Month 6 and Month 12 after first symptoms from SARS-CoV-2 infection.
      • Blood collection at 1st injection of vaccine against COVID-19, at at second injection of vaccine, at Month 1, Month 2, Month 6 and Month 12 after second injection of vaccine for volunteers
      • Poitiers, France
        C.H.U.de Poitiers
      Jun 22, 2022

      COVID-19, SARS-CoV-2 Trial in Seoul (QTP104 1ug, QTP104 5ug, QTP104 25ug)

      Active, not recruiting
      • COVID-19
      • SARS-CoV-2
      • QTP104 1ug
      • +2 more
      • Seoul, Korea, Republic of
      • +1 more
      May 24, 2023

      COVID-19 (SARS-CoV-2 Infection) Trial in Genova (Sentinox--Group A, Sentinox--Group B)

      Completed
      • COVID-19 (SARS-CoV-2 Infection)
      • Sentinox--Group A
      • Sentinox--Group B
      • Genova, Italy
        Ospedale Policlinico San Martino IRCCS
      Jul 25, 2022

      SARS-CoV-2 Infection Trial in Shinagawa-ku (S-217622, Placebo)

      Recruiting
      • SARS-CoV-2 Infection
      • Shinagawa-ku, Higashioi, Japan
        Tokyo Shinagawa Hospital Social Medical Corporation Association
      Jun 13, 2023

      Sars-CoV-2 Infection, COVID-19 Trial in Knoxville (Rapid SARS-CoV-2 Antigen Test)

      Completed
      • Sars-CoV-2 Infection
      • COVID-19
      • Rapid SARS-CoV-2 Antigen Test
      • Knoxville, Tennessee
        EDP Biotech Corporation
      Oct 14, 2022

      Sustained Immunity to COVID-19 as Measured by SARS-CoV-2

      Recruiting
      • Covid19
      • Serologic immunoassays to SARS-CoV-2 antibodies
      • Detroit, Michigan
        Henry Ford Health System
      Dec 13, 2022

      COVID-19 SARS-CoV-2 Infection Trial (CoronaVac, SCTV01E)

      Not yet recruiting
      • COVID-19 SARS-CoV-2 Infection
      • CoronaVac
      • SCTV01E
      • (no location specified)
      Jan 4, 2023

      Long-Term Sequelae of SARS-COV-2 Infection: Diabetes Mellitus

      Not yet recruiting
      • COVID-19
      • Diabete Mellitus
      • Measure of physiologic parameters
      • San Antonio, Texas
        Texas Diabetes Institute - University Health System
      May 17, 2023

      SARS CoV 2 Infection, COVID-19 Trial in Brussels (Humoral immunity)

      Enrolling by invitation
      • SARS CoV 2 Infection
      • COVID-19
      • Humoral immunity
      • Brussels, Belgium
        Sciensano
      Jan 16, 2023

      SARS-CoV-2 Infection Among Healthcare Workers

      Recruiting
      • COVID-19
      • inactivated COVID-19 vaccines; orally aerosolized Ad5-nCoV
      • Nanjing, Jiangsu, China
        The Affiliated Nanjing Drum Tower Hospital of Nanjing University
      Jan 10, 2023

      COVID19 Trial in San José (Breath sample)

      Withdrawn
      • COVID19
      • Breath sample
      • San José, Costa Rica
        Instituto Costarricense de Investigaciones Clínicas
      Nov 22, 2022

      NIH RECOVER Tissue Pathology: Understanding Long-Term Impact of

      Recruiting
      • COVID-19
      • SARS CoV 2 Infection
        • New York, New York
          NYU Langone Health
        Jan 25, 2023